PeptyPepty

Tag: MASH

Browse all articles tagged with “MASH”.

1 article

Metabolic Health

Survodutide: The Dual Glucagon/GLP-1 Agonist Targeting Liver Disease

A research overview of survodutide, the investigational dual glucagon/GLP-1 receptor agonist from Boehringer Ingelheim being developed for obesity and NASH/MASH, with a focus on its hepatic fat reduction potential.

2026-01-25·10 min read
SurvodutideglucagonGLP-1dual agonistNASHMASHliver diseaseBoehringer Ingelheimmetabolic health
←Back to blog

For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.